DRC Just Started Vaccinating for Ebola. There's Just One Catch.

The Democratic Republic of Congo has started rolling out Ebola vaccines, which sounds like excellent news. And it is! Except for one crucial detail: the vaccine they're using isn't actually designed for the specific Ebola strain currently wreaking havoc.

Yes, you read that right. Healthcare workers and other frontline staff in the DRC are now receiving doses of a vaccine known as Ervebo. The catch? Ervebo targets the Zaire strain of Ebola, while the current outbreak is caused by the Bundibugyo strain. Scientists are still figuring out if it even works against this particular variant.

A Vaccine, A Trial, And A Race Against Time

There's no approved vaccine or treatment specifically for Bundibugyo yet, though clinical trials are underway. So, what's happening now is a bit of a high-stakes experiment. The first vaccinations began in Kisangani, with Congo's health minister, Samuel Roger Kamba, confirming over 50,000 doses have arrived.

The current outbreak is largely concentrated in Ituri province, which borders Uganda. The plan is to expand vaccinations outwards from Ituri, moving towards the epicenter of the crisis. The World Health Organization (WHO) approved 70,000 Ervebo doses for the DRC, with about 20,000 of those earmarked for a clinical trial to test their effectiveness against the new strain. Health workers, understandably, are calling for more.

As of Tuesday, the DRC has reported a grim 5,713 confirmed Ebola cases and 2,744 deaths. This makes it the deadliest Ebola outbreak the country has ever faced. Controlling it has been a nightmare, thanks to ongoing insecurity, massive population displacement, and even a health worker strike. The WHO describes the situation as "out of control" and warns it could surpass the devastating 2014-2016 West Africa outbreak, which claimed over 11,000 lives. So, while a vaccine rollout is a step, it's a step into deeply uncertain territory.